publication venue for
- A Prospective, Observational Study of Patient-Reported Outcomes in Adult Chronic Migraine Patients Treated with OnabotulinumtoxinA: PREDICT Study Methods and Baseline Data 2016
- Canadian Headache Society Systematic Review & Recommendations on the Acute Treatment of Migraine Pain in Emergency Settings 2014
- Comparative Safety of Triptans, Non-Steroidal Anti-Inflammatory Drugs, and Ergotamines for the Acute Treatment of Migraine: A Network Meta-Analysis 2014
- Risk of Medication Overuse Headache Across Classes of Treatment for Migraine 2014
- Effect of prophylactic treatment with botulinum toxin type a on the cost of acute headache medication and health-related quality of life in patients with chronic migraine 2008
- TREATMENT OF POSTTRAUMATIC HEADACHE WITH AMITRIPTYLINE 1979
-
Readability analysis and concept mapping of
PROMs used for headache disorders. 64:410-423. 2024 - Erratum. 62:1242-1242. 2022
- A real‐world, observational study of erenumab for migraine prevention in Canadian patients. 62:522-529. 2022
-
Public Drug Coverage and Its Impact on Triptan Use Across
C anada: A Population‐Based Study. 55:212-220. 2015 - HIT‐6 and MIDAS as Measures of Headache Disability in a Headache Referral Population. 50:383-395. 2010
- Endothelial Function in Patients With Migraine During the Interictal Period. 47:45-51. 2007
- A Clinical Study of Migraine Evolution. 46:1480-1486. 2006
- Brush Allodynia in Hospitalized Headache Patients. 45:999-1003. 2005
- Migraine Patients Exhibit Abnormalities in the Visual Evoked Potential. 23:49-52. 1983
- Treatment of Post‐traumatic Headache with Amitriptyline. 20:213-216. 1980